Clinical Trial

PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this research study is to look at whether Eroxon® gel when used together with tadalafil, may help improve erectile function in men ages 18 to 40 who have type 2 diabetes.
Trial Details
NCT Number NCT07636161
Lead Sponsor University of Miami
Collaborators: Sexual Medicine Society of North America Inc.
Conditions Type 2 Diabetes, Type 2 Diabetes (T2DM)
Enrollment 30 participants
Start Date 2026-09
Primary Completion 2027-09 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-06-09